JP2007523640A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523640A5 JP2007523640A5 JP2006550132A JP2006550132A JP2007523640A5 JP 2007523640 A5 JP2007523640 A5 JP 2007523640A5 JP 2006550132 A JP2006550132 A JP 2006550132A JP 2006550132 A JP2006550132 A JP 2006550132A JP 2007523640 A5 JP2007523640 A5 JP 2007523640A5
- Authority
- JP
- Japan
- Prior art keywords
- axotrophin
- polypeptide
- polynucleotide
- derived
- encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0402051.7A GB0402051D0 (en) | 2004-01-29 | 2004-01-29 | Fate determination in immunity |
| PCT/EP2005/000934 WO2005074973A2 (en) | 2004-01-29 | 2005-01-31 | Method of inducing or modulating immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007523640A JP2007523640A (ja) | 2007-08-23 |
| JP2007523640A5 true JP2007523640A5 (enExample) | 2008-03-21 |
Family
ID=31971742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006550132A Withdrawn JP2007523640A (ja) | 2004-01-29 | 2005-01-31 | 免疫応答を誘導または調節する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070286807A1 (enExample) |
| EP (1) | EP1713495A2 (enExample) |
| JP (1) | JP2007523640A (enExample) |
| KR (1) | KR20070007291A (enExample) |
| CN (1) | CN1929855A (enExample) |
| AU (1) | AU2005210105A1 (enExample) |
| CA (1) | CA2560055A1 (enExample) |
| GB (1) | GB0402051D0 (enExample) |
| WO (1) | WO2005074973A2 (enExample) |
| ZA (1) | ZA200606331B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0402051D0 (en) * | 2004-01-29 | 2004-03-03 | Metcalfe Su | Fate determination in immunity |
| ATE508207T1 (de) * | 2006-02-28 | 2011-05-15 | Charite Universitaetsmedizin | Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens |
| GB0614536D0 (en) * | 2006-07-21 | 2006-08-30 | Metcalfe Susan M | Methods of controlling cellular response to LIF |
| GB0721081D0 (en) * | 2007-10-26 | 2007-12-05 | Metcalfe Susan M | Immuno-modulatory composition |
| US20120164659A1 (en) * | 2009-08-05 | 2012-06-28 | Nexigen Gmbh | Human hcv-interacting proteins and methods of use |
| WO2014031883A1 (en) | 2012-08-23 | 2014-02-27 | Susan Marie Metcalfe | Neurotherapeutic nanoparticle compositions and devices |
| US11779683B2 (en) * | 2019-04-08 | 2023-10-10 | Loubert S. Suddaby | Extended release immunomodulatory implant to facilitate bone morphogenesis |
| US11369473B2 (en) | 2019-04-08 | 2022-06-28 | Loubert S. Suddaby | Extended release immunomodulatory implant to facilitate bone morphogenesis |
| CN112843222B (zh) * | 2021-01-21 | 2023-01-31 | 暨南大学 | Ankrd22蛋白在制备治疗或延缓自身免疫性疾病的产品中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1074617A3 (en) * | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
| US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
| AU2003213606A1 (en) * | 2002-03-01 | 2003-10-13 | Exelixis, Inc. | MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| GB0402051D0 (en) * | 2004-01-29 | 2004-03-03 | Metcalfe Su | Fate determination in immunity |
-
2004
- 2004-01-29 GB GBGB0402051.7A patent/GB0402051D0/en not_active Ceased
-
2005
- 2005-01-31 US US10/587,995 patent/US20070286807A1/en not_active Abandoned
- 2005-01-31 AU AU2005210105A patent/AU2005210105A1/en not_active Abandoned
- 2005-01-31 WO PCT/EP2005/000934 patent/WO2005074973A2/en not_active Ceased
- 2005-01-31 ZA ZA200606331A patent/ZA200606331B/xx unknown
- 2005-01-31 EP EP05707096A patent/EP1713495A2/en not_active Withdrawn
- 2005-01-31 JP JP2006550132A patent/JP2007523640A/ja not_active Withdrawn
- 2005-01-31 KR KR1020067017432A patent/KR20070007291A/ko not_active Withdrawn
- 2005-01-31 CN CNA2005800072757A patent/CN1929855A/zh active Pending
- 2005-01-31 CA CA002560055A patent/CA2560055A1/en not_active Abandoned
-
2007
- 2007-10-17 US US11/873,586 patent/US20080125390A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105556308B (zh) | 用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物 | |
| CN109661578A (zh) | 用于区分细菌和病毒感染的蛋白质特征 | |
| JP2010539508A5 (enExample) | ||
| EP3298160B1 (en) | Method for predicting the response of melanoma patients to targeted pharmacotherapy | |
| JP2017506623A5 (enExample) | ||
| JP2009540803A5 (enExample) | ||
| CN102667484A (zh) | 识别黑素瘤肿瘤细胞的生物标记 | |
| KR20120093298A (ko) | 티보자닙 반응 예측 | |
| CN104422768A (zh) | 一种联合检测早期卵巢癌标志物的抗体芯片试剂盒 | |
| JP2007533985A5 (enExample) | ||
| CN107850589A (zh) | 13+/17+bin1表达作为心脏病症的标记 | |
| JP2021524576A (ja) | がんの診断及び治療のための組成物及び方法 | |
| JPWO2013038696A1 (ja) | 胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法 | |
| CN106716135A (zh) | 心力衰竭患者的检测方法、心脏疾病的识别方法、心力衰竭的检查试剂、心力衰竭的检查试剂盒、用于检测心力衰竭的装置及用于检测心力衰竭的程序 | |
| CN111936522B (zh) | 新型抗胸苷激酶抗体 | |
| CN107110848B (zh) | 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法 | |
| WO2003000925A1 (en) | Methods to identify signal sequences | |
| CN108738347B (zh) | 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒 | |
| Martin et al. | Surface plasmon resonance investigations of human epidermal growth factor receptor 2 | |
| US20120190563A1 (en) | Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor | |
| WO2018119003A1 (en) | Virus composite biosensor | |
| CN109633165A (zh) | 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用 | |
| Harris et al. | Affibodies as an alternative to antibodies in biosensors for cancer markers | |
| CA2486119A1 (en) | Method of isolating an endothelial cell and method of donor specific crossmatching | |
| JP5428004B2 (ja) | 消化管間質腫瘍を患う患者の予後を予測するためのキット |